Yvonne W. Rozendaal-Wesseling
Eindhoven, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.
Journal: Breast cancer research : BCR
Published: July 31, 2025
Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score.
Journal: Journal of clinical pathology
Published: December 13, 2023
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways.
Journal: The Journal of biological chemistry
Published: January 24, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 06, 2022
Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function.
Journal: Cancers
Published: December 17, 2021
Measurement of activity of developmental signal transduction pathways to quantify stem cell pluripotency and phenotypically characterize differentiated cells.
Journal: Stem cell research
Published: October 21, 2021
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.
Journal: Cancers
Published: August 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026